| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01:42 | Nu Q2'26 slides: profit tops $1B, risk-adjusted margin hits 12.4% | ||
| 01:18 | Afya 1H26 slides: revenue up 7%, margins narrow on investments | ||
| 01:06 | Alithya Q1 F2027 slides: soft quarter prompts strategic review | ||
| 01:06 | Nomad Foods Q2 2026 slides: margins expand despite volume pressure | ||
| 01:06 | Nomad Foods Q2 2026 slides: margins expand despite retail disruptions | ||
| 00:42 | Soluna Q2 2026 slides: revenue surges 145% amid AI pivot | ||
| 00:42 | dLocal Q2 2026 slides: TPV surges 92%, guidance raised on broad growth | ||
| 00:42 | Soluna Q2 2026 slides: 145% revenue surge masks profitability pressure | ||
| 00:42 | Valvoline prices $600 million senior notes offering at 6.125% | ||
| 00:42 | Veritone Q2 2026 presentation: data refinery growth, stock drops 23% | ||
| 00:42 | StoneCo Q2 2026 slides: credit growth amid rising NPLs, revenue misses | ||
| 00:42 | Globant Q2 2026 slides: AI pods surge as core business faces headwinds | ||
| 00:42 | Jefferson Capital Q2 2026 slides: auto finance drives 18% collection growth | ||
| 00:42 | Jefferson Capital Q2 2026 slides: collections surge 18% on auto push | ||
| 00:30 | Midera Q2 2026 slides: spin-off debut beats guidance, organic growth lags | ||
| 00:30 | Health In Tech Q2 2026 slides: growth plans meet execution challenges | ||
| 00:30 | Innventure Q2 2026 slides: pivot to milestones as stock sinks 47% | ||
| 00:30 | Kyntra Bio Q2 2026 slides: dual catalysts expected, cash into 2028 | ||
| 00:30 | Kyntra Bio Q2 2026 slides: prostate cancer, MDS programs eye Q4 catalysts | ||
| 00:18 | Elutia Q2 2026 slides: $26M capital raise funds NXT41x launch | ||
| 00:18 | Applied Materials Q3 FY2026 slides: record results, raised outlook | ||
| 00:18 | Digimarc Q2 2026 slides: new CEO narrows focus amid ARR decline | ||
| 00:18 | KinderCare Q2 2026 slides: enrollment woes drive EBITDA decline | ||
| 00:18 | Bitwise explores tokenized shares for Solana ETF with Superstate | ||
| 00:18 | York Space Q2 2026 slides: strong execution, but guidance cut hits stock |